Efranat's Angel Round

Efranat raised a round of funding on November 01, 2011. Investors include Shmuel Cabily.

Efranat develops a unique anti-cancer immunotherapy treatment based on a natural plasma protein molecule named GcMAF. The concept underlying the technology is to engage the body's own immune system an…

Articles about Efranat's Angel Round: